Cumberland Pharmaceuticals (CPIX) EBITDA Margin Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 304.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -157.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -650.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -3,172.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2,080.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 152.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -17,785.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,472.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -583.00 |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn | -4,530.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,530.00 |
| Dec 31, 2025 | 763.00 |
| Sep 30, 2025 | -505.00 |
| Jun 30, 2025 | 353.00 |
| Mar 31, 2025 | 3,303.00 |
| Dec 31, 2024 | 4,841.00 |
| Sep 30, 2024 | -14.00 |
| Jun 30, 2024 | -1,063.00 |
| Mar 31, 2024 | -539.00 |
| Dec 31, 2023 | -4,110.00 |
| Sep 30, 2023 | -1,598.00 |
| Jun 30, 2023 | 1,814.00 |
| Mar 31, 2023 | -504.00 |
| Dec 31, 2022 | 2,737.00 |
| Sep 30, 2022 | 1,684.00 |
| Jun 30, 2022 | -207.00 |
| Mar 31, 2022 | -848.00 |
| Dec 31, 2021 | -3,532.00 |
| Sep 30, 2021 | -630.00 |
| Jun 30, 2021 | 62.00 |